Logo
Logo

Powering Global Health with Trusted, High-Quality APIs

Dr. Reddy’s API business is a leading manufacturer and supplier of high-quality quality affordable Active Pharmaceutical Ingredients (APIs) to leading generic formulations manufacturers across the world, enabling them to accelerate access to affordable medicines for patients worldwide. As a preferred partner across major markets, we lead with sustainability, first-to-market products, and an unwavering commitment to quality.

Who we are

At Dr. Reddy’s, we believe that access to affordable, high-quality medicines starts with world-class APIs.

At Dr. Reddy’s, we enable access to affordable, high-quality medicines through our trusted API portfolio. With 250+ APIs supplied across 80+ countries, we are a preferred partner to leading generic manufacturers worldwide including in the U.S., Europe, Latin America, Japan, China, Korea, and emerging markets.

Backed by 40+ years of scientific excellence, we specialize in complex APIs such as steroids, peptides, long-chain molecules, and highly potent oncology drugs. Our deep R&D capabilities, strong IP management, and rigorous regulatory compliance ensure speed-to-market, reliability, and quality.

We prioritize sustainable innovation and operational excellence, helping our partners stay ahead in competitive markets. Together, we’re shaping a healthier future.

Scientist working in lab

Our Journey

1984-2001
2010-2012
2013-2018
2019-2020
2021
2022
2023
2024
Logo
1984-2001

Logo
2010-2012

Logo
2013-2018

Logo
2019-2020

Logo
2021

2021

Our company played its part along with the rest of the pharma industry in the fight against COVID-19.

We combined our in-house efforts with an open-innovation model of partnerships to make available a portfolio that included a vaccine, and therapeutics for mild, moderate, and severe COVID-19.

Our focus on agility, access, and affordability helped us reach over 5 million patients during the pandemic, especially in low- and middle-income countries.

Logo
2022

2022

Our biggest manufacturing facility in Hyderabad was recognized by the World Economic Forum as part of its Global Lighthouse Network for leadership in the use of Industry 4.0 technologies.

Dr. Reddy's Foundation received a National Award from the President of India for the Empowerment of Persons with Disabilities.

We refreshed our ESG goals to make them bold, measurable, accountable, and central to business strategy.

We were named by the prestigious Science Magazine as among the Top 20 employers globally in pharma/biotech.

We launched Lenalidomide Capsules in the U.S. with two of six strengths eligible for first-to-file, 180-day exclusivity

Logo
2023

2023

We became the first Indian pharma company to debut on the Dow Jones Sustainability World Index.

We launched Nerivio® in India for migraine management, marking our foray into digital therapeutics.

We entered into strategic collaborations for novel molecules - with the U.S.-based Coya Therapeutics for a novel combination biologic for ALS; with China-based Junshi Biosciences for Toripalimab; and with Jiangsu Hengrui for Pyrotinib.

We were included in the Bloomberg Gender-Equality Index for the 6th year in a row.

Logo
2024

2024

We diversified our offerings to patients – women’s healthcare in the U.S., consumer healthcare and our first-ever biosimilar in the UK, and vaccines in India.

We agreed with Nestlé India to form a joint venture to introduce health science nutraceutical products to consumers across India and other agreed territories.

We signed a definitive agreement with Haleon plc to acquire Nicotinell and its related portfolio in Nicotine Replacement Therapy, in a significant step towards building a global consumer healthcare business, outside of the US. This is our biggest acquisition yet.

Excellence and Legacy

40+

Years of serving patients

250+

Active pharmaceutical Ingredients

1980+

DMFs filed globally

2000+

Research scientists working on various projects

83+

Countries (Global Presence)

26000+

Employees Globally (57 Nationalities)

756M

Patients access our therapies every year

3.8B

Billion USD revenue

329+

Abbreviated New Drug Applications (ANDAs)

Our Promises

Pill Icon

Bringing essential medicines within reach

Pill Icon

Addressing unmet patient needs

Pill Icon

Addressing unmet patient needs

Pill Icon

Working with partners to help them succeed

Pill Icon

Helping patients manage disease better

Our Team

Deepak Sapra

Deepak Sapra

Chief Executive Officer, API and Services

Learn more

Deepak Sapra

Deepak Sapra is a distinguished business leader, author, and social entrepreneur, currently CEO of PSAI at Dr. Reddy’s Laboratories and board member at APSL (a subsidiary of Dr. Reddy’s Laboratories). An IIM Bangalore and IRIMEE alumnus. He has also been awarded prestigious international fellowships, including the Chevening Scholarship (UK) and the Fulbright Fellowship (USA). He co-founded Priyajan, driving inclusive development in rural India. Through his diverse portfolio of leadership, writing, and community initiatives, he continues to shape both the business and human sides of healthcare and public service.

Amit Parekh

Amit Parekh

Vice President & Head of Finance

Learn more

Amit Parekh

Amit Parekh serves as Vice President & Head – PSAI (API & APSL), API Finance at Dr. Reddy’s Laboratories. Amit balances business growth with strong governance, believing finance is both a growth enabler and the organization’s last line of defence. He is passionate about driving results through business partnering, financial planning, reporting, M&A, and strategic decision-making.

Azhar Khan

Azhar Khan

Vice President and Head, Key Account Management & DPEX (API)

Learn more

Azhar Khan

Azhar is a seasoned leader with over 18 years of experience in business building, digital transformation, strategy, and product leadership. In his current role as the Global Head of Digital & Technology (PSAI) at Dr. Reddy's Laboratories, he leads the customer success and business growth for the region, as well as builds a digital platform business and leads digital transformation and technology initiatives across the organization. 

B. Vivek

B. Vivek

Executive VP & Global Head - Supply, Demand Planning & Delivery

Learn more

B. Vivek

B. Vivek is Executive Vice President and Global Head of Supply, Demand Planning & Delivery at Dr. Reddy’s Laboratories. He plays a pivotal role in ensuring end-to-end supply continuity, customer satisfaction, and operational resilience across global markets. In his additional capacity as Vice President and Global Delivery Head for Project Management (API & Formulations), Vivek leads cross-functional teams that drive innovation, efficiency, and speed-to-market for strategic partnerships and CDMO engagements.

Dr. A Kalyan Chakravarthy

Dr. A Kalyan Chakravarthy

Executive Vice President, SEAMEA & B2B Formulations

Learn more

Dr. A Kalyan Chakravarthy

Dr. A. Kalyan Chakravarthy is a seasoned pharmaceutical leader with over two decades of experience in drug development, formulation innovation & regulatory affairs. He currently serves as Executive Vice President and Head – SEMEA and B2B Formulations. His tenure in the pharmaceutical industry reflects a deep understanding of technical, operational, and regulatory complexities spanning both emerging and developed markets.

Dr. NM Sekhar

Dr. NM Sekhar

Vice President, API R&D

Learn more

Dr. NM Sekhar

Dr. NM Sekhar is a seasoned R&D leader with 29 years of experience in pharmaceutical product development, regulatory strategy, and global program management. He has led over 80 products from concept to commercial launch, authored 25+ patents and publications, and driven innovation through cost-effective, IP-compliant solutions. Known for excellence in API development, cross-functional leadership, and mentoring, he is a multiple award recipient for speed, functional impact, and business growth.

Dr. Rajeev Rehani Budhdev

Dr. Rajeev Rehani Budhdev

Executive Vice President, API R&D

Learn more

Dr. Rajeev Rehani Budhdev

Dr. Rajeev Rehani Budhdev currently serves as the Executive Vice President and Head of API R&D at Dr. Reddy’s Laboratories. Renowned for championing novel technologies, including continuous manufacturing and flow chemistry, he brings strategic vision to every stage of API innovation.

E Sreedhar

E Sreedhar

Executive Vice President, Regulatory Affairs

Learn more

E Sreedhar

E. Sreedhar is the Executive Vice President and Head of API Regulatory Affairs, with over 30 years of experience in pharmaceutical regulatory strategy, he oversees global regulatory affairs of Dr. Reddy’s, ensuring compliance with international regulatory agencies. His collaborative leadership, commitment to documentation excellence, and focus on patient-centric compliance have made him a key force behind Dr. Reddy’s reputation as a trusted global API supplier.

Gustavo Mayrink De Castro Marques

Gustavo Mayrink De Castro Marques

Vice President and Head, API Sales & Marketing, LATAM & Mexico

Learn more

Gustavo Mayrink De Castro Marques

A seasoned pharmaceutical leader with over two decades of industry experience, including 17 years leading international operations across Latin America and Mexico. As Vice President of API Sales & Marketing, he has consistently delivered growth through strategic P&L management, start-up operations, and expansive sales, marketing, technical, and business development leadership.

Kalpesh Modi

Kalpesh Modi

Vice President and Head, Europe

Learn more

Kalpesh Modi

Kalpesh leads strategic growth across regulated markets, focusing on building global pharma partnerships that enable patient access, innovation, and sustainable supply chains. With over 20 years of experience across Europe, CIS, Israel, and Asia-Pacific, Kalpesh specializes in expanding API/CDMO business across geographies and therapeutic areas, driving complex licensing and out-licensing deals, leading cross-functional commercial teams across emerging and developed markets, & Delivering P&L performance and long-term strategic collaborations.

Karun Gaur

Karun Gaur

Vice President, Strategic Alliances & Access

Learn more

Karun Gaur

Karun Gaur is an accomplished pharmaceutical industry leader with decades of global experience spanning API marketing, regional business leadership, and strategic healthcare alliances. Currently serving as Vice President & Head of Strategic Alliances & Access at Dr. Reddy’s Laboratories, Karun drives initiatives to expand access to quality healthcare across emerging markets through technology transfer, local manufacturing support, and collaborative partnerships.

Lalitha Kumari

Lalitha Kumari

Global Head of API Product Management & Head of Sales - US & Canada

Learn more

Lalitha Kumari

No bio available.

Nirav Shah

Nirav Shah

Vice President and Head, North Asia

Learn more

Nirav Shah

With nearly 28 years at Dr. Reddy’s Laboratories, Nirav Shah is a powerhouse of strategic leadership and commercial excellence in the global pharmaceutical industry. Currently serving as Vice President – North Asia, Nirav drives market growth and profitability across API, formulations, and biosimilars by building resilient business ecosystems and nurturing high-impact customer relationships. 

RV Ramesh

RV Ramesh

Executive Vice President & Global Head - Manufacturing, Chemical Technical Operations

Learn more

RV Ramesh

RV Ramesh is a strategic manufacturing leader with extensive global experience in chemical technical operations and end-to-end pharmaceutical manufacturing. As Executive Vice President and Global Head, RV Ramesh has led large-scale operations with a focus on operational excellence, quality compliance, and cost optimization. Known for building high-performing teams, driving continuous improvement, and implementing robust systems across global sites.

Sudeshna Mitra

Sudeshna Mitra

P&O Head- Biologics, AOL, PSAI, Global Talent Management Head

Learn more

Sudeshna Mitra

Seasoned Human Resources leader with a career spanning over 15 years across various roles in the pharmaceutical industry. Championed forward-thinking HR practices that have helped redefine the organisation’s talent landscape. Worked across roles in business HR, driving performance. Led organisation-wide transformation interventions in the space of organisation effectiveness, employee experience, and talent management.

Dr. Reddy’s Global Management Council

To read about the leaders of the organisation worldwide at Dr. Reddy’s website

Know More

Sustainability message
from the CEO

Sustainability is at the core of our mission at Dr. Reddy’s. We are committed to minimizing our environmental footprint, empowering communities, and ensuring ethical business practices. Together, we can build a healthier planet for future generations.

Deepak Sapra

CEO, Pharmaceutical Services & Active Ingredients